VESALIUS THERAPEUTICS
Vesalius Therapeutics is focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.
VESALIUS THERAPEUTICS
Industry:
Health Care Medical
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vesaliustx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
75 M USD
Technology used in webpage:
Domain Not Resolving Digital Ocean
Similar Organizations
Tarveda Therapeutics
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Curie Therapeutics
Curie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
ITeos Therapeutics
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
KayoThera
KayoThera develops therapeutics used to cure late-stage and metastatic cancers.
University of Minnesota Medical Center, Fairview
Minnesota Medical Center is inpatient and outpatient facilities and connected with six community clinics and many specialty clinics.
VLP Therapeutics
VLP is a biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment.
Wellvana
Wellvana provides the required infrastructure to enable the collaboration of independent medical providers.
Current Advisors List
Investors List
Flagship Pioneering
Flagship Pioneering investment in Series A - Vesalius Therapeutics
Official Site Inspections
http://www.vesaliustx.com Semrush global rank: 15.54 M Semrush visits lastest month: 2
- Host name: 688508.cloudwaysapps.com
- IP address: 159.223.187.165
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vesalius Therapeutics"
Vesalius | Home
He has served on the boards of the Biotechnology Innovation Organization (BIO), as well as Flagship’s companies: Moderna (NASDAQ: MRNA), Axcella Therapeutics and Editas Medicine (NASDAQ: EDIT). John currently serves on …See details»
Vesalius Therapeutics - Crunchbase Company Profile
Organization. Vesalius Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Vesalius Therapeutics - LinkedIn
Vesalius Therapeutics | 2,925 followers on LinkedIn. Pioneering a revolutionary platform to generate breakthrough treatments for common diseases | Pioneering a revolutionary platform …See details»
Vesalius Therapeutics - Flagship Pioneering
Vesalius Therapeutics is a company pioneering a radical approach to common disease drug development. Its precision platform, Continuum Discovery™, integrates AI/ML analysis of …See details»
Vesalius Therapeutics Announces Leadership Transition - Flagship …
Cambridge, Mass, March 7, 2024 – Vesalius Therapeutics, a company pioneering a radical approach to common disease drug development, today announced that John Mendlein, Ph.D., …See details»
Flagship Pioneering Unveils Vesalius… | Flagship Pioneering
Mar 2, 2022 For more information visit vesaliustx.com, or follow us on Twitter and LinkedIn. About Flagship Pioneering. Flagship Pioneering conceives, creates, resources, and develops …See details»
Vesalius Therapeutics Company Profile -Sales, Contacts, …
Www.vesaliustx.com: There are 68 Companies located at 55 CAMBRIDGE PKWY, Cambridge, MA 02142 Map View larger ... This organization primarily operates in the Testing Laboratories …See details»
Vesalius Therapeutics Inc. Company Profile | Cambridge, MA ...
Find company research, competitor information, contact details & financial data for Vesalius Therapeutics Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Org Chart Vesalius Therapeutics - The Official Board
For each of our 1,282,034 listed executives, discover their exact roles and their biographies.See details»
Vesalius Therapeutics - Craft
Vesalius Therapeutics is a company that provides healthcare services. It develops a biotechnology platform that links clinical patterns to the combined effects of different genes …See details»
Vesalius Therapeutics CEO and Key Executive Team | Craft.co
Vesalius Therapeutics's Director is Doug Cole. Other executives include Christopher P. Austin, CEO, Director; Ben Munoz, SVP, Head of Drug Discovery and 3 others. See the full leadership …See details»
Leadership - Vesalius
At Flagship, John contributes to Flagship’s strategic and operational objectives, including the origination of new Flagship Labs companies and growth companies. He also serves on the …See details»
Vesalius Therapeutics lands $75m - venturecapitaljournal.com
Mar 2, 2022 For more information visit vesaliustx.com, or follow us on Twitter and LinkedIn. TAGS; Healthcare; Share this. Twitter. Linkedin. MOST RECENT. UPCOMING EVENTS. …See details»
Vesalius Announces Multi-Target Strategic Alliance with GSK to …
Nov 12, 2024 For more information visit vesaliustx.com, or follow us on X and LinkedIn. Media Contact: [email protected] SOURCE Vesalius Therapeutics. WANT YOUR COMPANY'S …See details»
Flagship Pioneering Unveils Vesalius Therapeutics to Revolutionize …
Mar 2, 2022 For more information visit vesaliustx.com, or follow us on Twitter and LinkedIn. About Flagship Pioneering Flagship Pioneering conceives, creates, resources, and develops …See details»
Vesalius Therapeutics - Drug pipelines, Patents, Clinical trials
May 8, 2025 www.vesaliustx.com. Last update 08 May 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. …See details»
Vesalius Announces Multi-Target Strategic… | Flagship Pioneering
Nov 12, 2024 Efficiently identifying these intervention points and the patients most likely to benefit from these novel therapies will enable smaller, shorter clinical trials with a higher …See details»
Vesalius Therapeutics - Work in biotech
Vesalius is redefining how we define and treat common illnesses. Common illnesses such as heart failure, high blood pressure, type II diabetes and obesity have a single diagnosis, yet are …See details»
Vesalius Therapeutics (Vesalius Therapeutics) - 药物管线_专利_临 …
GSK is looking for hints of causality in Mendelian genetics—or patterns in biological inheritance—that cause significant disease early in life.\n Following GSK’s deal-heavy end to …See details»
Vesalius Announces Multi-Target Strategic Alliance with GSK
Nov 12, 2024 Efficiently identifying these intervention points and the patients most likely to benefit from these novel therapies will enable smaller, shorter clinical trials with a higher …See details»